Setting and managing patient expectations is an important part of the therapeutic process. To ensure patient acceptance and compliance with LEVULAN KERASTICK and BLU-U® PDT you must clearly communicate to them what they should expect before, during and after therapy. What follows is the step by step process including post treatment expectations.
- Provide patient with the patient insert and review potential side effects.
- Be sure to ask if patients are taking any oral medications or using any topical prescription or non-prescription products on their face or scalp. LEVULAN KERASTICK and BLU-U PDT is contraindicated in patients with cutaneous photosensitivity at wavelengths of 400-450 nm, porphyria, or known allergies to porphyrins, and in patients with known sensitivity to any of the components of the LEVULAN KERASTICK for Topical Solution.
- On treatment days remind patients to bring a wide-brimmed hat or adequate sun-protective item to shield the treated lesions from sunlight or other forms of bright light.
- Remind patients to not wash their face in between treatment steps.
- Remind patients to avoid exposure of the treated lesions to sunlight and other forms of bright light for at least 40 hours. Examples include exam room examination lights, operating room lamps, tanning bed lights, and household lights at close range. Sunscreens will not protect against photosensitivity reactions caused by visible light during this time.
- Inform patients that they may experience sensations of tingling, stinging (sometimes severe), prickling or burning of the treated AK lesions.
- Patients and medical personnel must wear blue blocking protective eyewear.
- Inform patients that they may apply moisturizers as needed.
- Inform patients that following treatment, their treated AKs and to some degree the surrounding skin may redden. Swelling, scaling, and itching may also occur. However, these effects are temporary and should completely resolve by 4 weeks after treatment.
For additional information or support, please contact DUSA Medical Affairs at (877) 799-3872.
WEB 1458 Rev E